Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir

被引：0
|
作者：
Clotilde Le Tiec
Aurélie Barrail
Cécile Goujard
Anne-Marie Taburet
机构：
[1] Assistance Publique Hôpitaux de Paris (AP-HP),Clinical Pharmacy Department, Hôpital Bicêtre
[2] Assistance Publique Hôpitaux de Paris (AP-HP),Internal Medicine Department, Hôpital Bicêtre
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Ritonavir; Tenofovir; Efavirenz; Didanosine; Saquinavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The efficacy of HIV-1 protease inhibitors (PIs) as part of highly active antiretroviral therapy is now well established and has provided benefits to many patients with HIV infection. Atazanavir is a new azapeptide PI compound that was recently approved in the US and Europe. Atazanavir is recommended in combination with other antiretroviral agents for the treatment of HIV-1 infection.
引用
收藏
页码：1035 / 1050
页数：15
相关论文
共 50 条
  • [1] Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir
    Le Tiec, C
    Barrail, A
    Goujard, U
    Taburet, AM
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (10) : 1035 - 1050
  • [2] PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics
    Alvarellos, Maria
    Guillemette, Chantal
    Altman, Russ B.
    Klein, Teri E.
    [J]. PHARMACOGENETICS AND GENOMICS, 2018, 28 (05): : 127 - 137
  • [3] An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability
    Crouse, John R., III
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (03) : 287 - 304
  • [4] Atazanavir for treatment of HIV infection in clinical routine:: Efficacy, pharmacokinetics and safety
    Feldt, T
    Oette, M
    Kroidl, A
    Göbels, K
    Leidel, R
    Sagir, A
    Kuschak, D
    Häussinger, D
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2005, 10 (01) : 7 - 10
  • [5] The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide
    Lee, Noel
    Wald, Arnold
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (05) : 651 - 659
  • [6] Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability
    Bernstein, Jonathan A.
    Qazi, Momina
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (01) : 29 - 39
  • [7] Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability
    Bernstein, Jonathan A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2441 - 2452
  • [8] Atazanavir pharmacokinetics, efficacy and safety in pregnancy: a systematic review
    Eley, Timothy
    Bertz, Richard
    Hardy, Helene
    Burger, David
    [J]. ANTIVIRAL THERAPY, 2013, 18 (03) : 361 - 375
  • [9] Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
    Citrome, Leslie
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (02) : 193 - 206
  • [10] Efficacy, tolerability, and pharmacokinetics of Eletriptan in women
    MacGregor, A
    Alderman, J
    Sikes, C
    Hettiarachchi, J
    [J]. CEPHALALGIA, 2003, 23 (07) : 688 - 688
12345